Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 8/2006

01.08.2006 | Concise Article

Changing trends in etiology of bacteremia in patients with cancer

verfasst von: A. Safdar, G. H. Rodriguez, M. Balakrishnan, J. J. Tarrand, K. V. I. Rolston

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 8/2006

Einloggen, um Zugang zu erhalten

Abstract

The present study was conducted to determine trends in the quantitative bacterial load patterns of bacterial bloodstream infections (BSI) caused by various bacteria in patients receiving care at a comprehensive cancer center. Bacterial loads of all consecutive quantitative blood cultures performed during 1998 and 2004 were graded quantitatively. Gram-positive bacteria (GPB) were responsible for the majority of BSI episodes in both years studied: 740 of 1,055 (73%) in 1998 and 820 of 1,025 (82%) in 2004. Compared with GPB infections, a significant proportion of infections caused by Gram-negative bacteria was associated with a high bacterial load (HBL) (11 vs 28% in 1998 and 10 vs 30% in 2004; p<0.001). In 2004, BSI episodes due to non-Pseudomonas non-fermentative GNB (Stenotrophomonas maltophilia and Acinetobacter spp) were significantly associated with a HBL compared to BSI due to Pseudomonas aeruginosa (47 vs 23%; p<0.05); this was not the case in 1998. Conversely, the HBLs commonly associated with BSI due to Staphylococcus aureus (50%) and Streptococcus spp (35%) versus coagulase-negative staphylococci (13%; p<0.0001) during 1998 were not noted during 2004 (22% Staphylococcus aureus, 20% Streptococcus spp, 21% coagulase-negative staphylococci; p>0.5). The spectrum of BSI continues to change and its prognostic implications in cancer patients needs further study.
Literatur
1.
Zurück zum Zitat Safdar A, Armstrong D (2001) Infectious morbidity in critically ill patients with cancer. Critical Care Clin 17:531–570CrossRef Safdar A, Armstrong D (2001) Infectious morbidity in critically ill patients with cancer. Critical Care Clin 17:531–570CrossRef
2.
Zurück zum Zitat Rolston KV (2004) The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments. Clin Infect Dis 39(Suppl 1):44–48CrossRef Rolston KV (2004) The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments. Clin Infect Dis 39(Suppl 1):44–48CrossRef
3.
Zurück zum Zitat Chatzinikalaou I, Abi-Said D, Bodey GP, Rolston KVI, Tarrand JJ, Samonis G (2000) Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer. Arch Intern Med 160:501–509CrossRef Chatzinikalaou I, Abi-Said D, Bodey GP, Rolston KVI, Tarrand JJ, Samonis G (2000) Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer. Arch Intern Med 160:501–509CrossRef
4.
Zurück zum Zitat Rolston KVI, Tarrand JJ (1999) Pseudomonas aeruginosa—still a frequent pathogen in patients with cancer: 11-year experience at a comprehensive cancer center. Clin Infect Dis 29:463–464PubMedCrossRef Rolston KVI, Tarrand JJ (1999) Pseudomonas aeruginosa—still a frequent pathogen in patients with cancer: 11-year experience at a comprehensive cancer center. Clin Infect Dis 29:463–464PubMedCrossRef
5.
Zurück zum Zitat Douard MC, Arlet G, Leverger G, Paulien R, Waintrop C, Clementi E, Eurin B, Schaison G (1991) Quantitative blood cultures for diagnosis and management of catheter-related sepsis in pediatric hematology and oncology patients. Intensive Care Med 17:30–35PubMedCrossRef Douard MC, Arlet G, Leverger G, Paulien R, Waintrop C, Clementi E, Eurin B, Schaison G (1991) Quantitative blood cultures for diagnosis and management of catheter-related sepsis in pediatric hematology and oncology patients. Intensive Care Med 17:30–35PubMedCrossRef
6.
Zurück zum Zitat Germanakis J, Stiakaki E, Galanakis E, Christidou A, Neonakis J, Dimitriou H, Tselentis Y, Kalmanti M (2002) Prognostic value of quantitative blood cultures for the outcome of central venous catheters in children. Scand J Infect Dis 34:680–682PubMedCrossRef Germanakis J, Stiakaki E, Galanakis E, Christidou A, Neonakis J, Dimitriou H, Tselentis Y, Kalmanti M (2002) Prognostic value of quantitative blood cultures for the outcome of central venous catheters in children. Scand J Infect Dis 34:680–682PubMedCrossRef
7.
Zurück zum Zitat Safdar A, Raad II (2004) Management and treatment. In: O’Grady N, Pittet D (eds) Catheter-related infections in the critically ill. Kluwer, Boston, pp 99–112CrossRef Safdar A, Raad II (2004) Management and treatment. In: O’Grady N, Pittet D (eds) Catheter-related infections in the critically ill. Kluwer, Boston, pp 99–112CrossRef
8.
Zurück zum Zitat Backes RJ, Rouse MS, Henry NK, Geraci JE, Wilson WR (1986) Activity of penicillin combined with an aminoglycoside against group B Streptococcus in vitro and in experimental endocarditis. J Antimicrob Chemother 18:491–498PubMedCrossRef Backes RJ, Rouse MS, Henry NK, Geraci JE, Wilson WR (1986) Activity of penicillin combined with an aminoglycoside against group B Streptococcus in vitro and in experimental endocarditis. J Antimicrob Chemother 18:491–498PubMedCrossRef
9.
Zurück zum Zitat Baddour LM, Christensen GD, Bisno AL (1987) Bacterial concentration correlates in experimental endocarditis caused by Staphylococcus epidermidis. J Clin Microbiol 25:207–210PubMed Baddour LM, Christensen GD, Bisno AL (1987) Bacterial concentration correlates in experimental endocarditis caused by Staphylococcus epidermidis. J Clin Microbiol 25:207–210PubMed
10.
Zurück zum Zitat Enzler MJ, Rouse MS, Henry NK, Wilson WR (1987) In vitro and in vivo studies of streptomycin-resistant, penicillin-susceptible streptococci from patients with infective endocarditis. J Infect Dis 155:954–958PubMed Enzler MJ, Rouse MS, Henry NK, Wilson WR (1987) In vitro and in vivo studies of streptomycin-resistant, penicillin-susceptible streptococci from patients with infective endocarditis. J Infect Dis 155:954–958PubMed
11.
Zurück zum Zitat Garrison PK, Freedman LR (1970) Experimental endocarditis: I. Staphylococcus endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart. Yale J Biol Med 42:394–410PubMed Garrison PK, Freedman LR (1970) Experimental endocarditis: I. Staphylococcus endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart. Yale J Biol Med 42:394–410PubMed
12.
Zurück zum Zitat Yuste J, Jado I, Gimenez MJ, Aguilar L, Molero F, Fenoll A, Casal J (2002) Modification of bacteremia by specific antibodies and relation with mortality in pneumococcal mouse sepsis model. Clin Exp Immunol 128:411–415PubMedCrossRef Yuste J, Jado I, Gimenez MJ, Aguilar L, Molero F, Fenoll A, Casal J (2002) Modification of bacteremia by specific antibodies and relation with mortality in pneumococcal mouse sepsis model. Clin Exp Immunol 128:411–415PubMedCrossRef
13.
Zurück zum Zitat Whimbey E, Kiehn TE, Brannon P, Benezra D, Armstrong D (1987) Clinical significance of colony counts in immunosuppressed patients with Staphylococcus aureus bacteremia. J Infect Dis 155:1328–1330PubMed Whimbey E, Kiehn TE, Brannon P, Benezra D, Armstrong D (1987) Clinical significance of colony counts in immunosuppressed patients with Staphylococcus aureus bacteremia. J Infect Dis 155:1328–1330PubMed
14.
Zurück zum Zitat Schonheyder HC, Gottschau A, Friland A, Rosdahl VT (1995) Mortality rate and magnitude of Staphylococcus aureus bacteremia as assessed by a semiquantitative blood culture system. Scand J Infect Dis 27:19–21PubMedCrossRef Schonheyder HC, Gottschau A, Friland A, Rosdahl VT (1995) Mortality rate and magnitude of Staphylococcus aureus bacteremia as assessed by a semiquantitative blood culture system. Scand J Infect Dis 27:19–21PubMedCrossRef
15.
Zurück zum Zitat Elting LS, Rubenstein EB, Rolston KVI, Bodey GP (1997) Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 25:247–259PubMedCrossRef Elting LS, Rubenstein EB, Rolston KVI, Bodey GP (1997) Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 25:247–259PubMedCrossRef
16.
Zurück zum Zitat Tarrand JJ, Guillot C, Wenglar M, Jackson J, Lajeunesse JD, Rolston KV (1991) Clinical comparison of the resin-containing BACTEC 26 Plus and the Isolator 10 blood culturing systems. J Clin Microbiol 29:2245–2249PubMed Tarrand JJ, Guillot C, Wenglar M, Jackson J, Lajeunesse JD, Rolston KV (1991) Clinical comparison of the resin-containing BACTEC 26 Plus and the Isolator 10 blood culturing systems. J Clin Microbiol 29:2245–2249PubMed
17.
Zurück zum Zitat Vuong C, Gerke C, Somerville GA, Fischer ER, Otto M (2003) Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J Infect Dis 188:706–718PubMedCrossRef Vuong C, Gerke C, Somerville GA, Fischer ER, Otto M (2003) Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J Infect Dis 188:706–718PubMedCrossRef
18.
Zurück zum Zitat Walsh AL, Smith MD, Wuthiekanun V, Suputtamongkol Y, Chaowagul W, Dance DA, Angus B, White NJ (1995) Prognostic significance of quantitative bacteremia in septicemic melioidosis. Clin Infect Dis 21:1498–1500PubMed Walsh AL, Smith MD, Wuthiekanun V, Suputtamongkol Y, Chaowagul W, Dance DA, Angus B, White NJ (1995) Prognostic significance of quantitative bacteremia in septicemic melioidosis. Clin Infect Dis 21:1498–1500PubMed
19.
Zurück zum Zitat Vidal F, Mensa J, Almela M, Olona M, Martinez JA, Marco F, Lopez MJ, Soriano A, Horacajada JP, Gatell JM, Richart C (2003) Bacteremia in adults due to glucose non-fermentative gram-negative bacilli other than P. aeruginosa. QJM 96:227–234PubMedCrossRef Vidal F, Mensa J, Almela M, Olona M, Martinez JA, Marco F, Lopez MJ, Soriano A, Horacajada JP, Gatell JM, Richart C (2003) Bacteremia in adults due to glucose non-fermentative gram-negative bacilli other than P. aeruginosa. QJM 96:227–234PubMedCrossRef
20.
Zurück zum Zitat Apisarnthanarak A, Mayfield JL, Garison T, McLendon PM, DiPersio JF, Fraser VJ, Polish LB (2003) Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study. Infect Control Hosp Epidemiol 24:269–274PubMedCrossRef Apisarnthanarak A, Mayfield JL, Garison T, McLendon PM, DiPersio JF, Fraser VJ, Polish LB (2003) Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study. Infect Control Hosp Epidemiol 24:269–274PubMedCrossRef
21.
Zurück zum Zitat Aisenberg G, Rolston K, Kontoyiannis DM, Raad I, Safdar A (2005) Stenotrophomonas maltophilia pneumonia (SmP) in 108 patients with cancer: matched case-control analysis in 44 individuals with low-risk of infection (1998–2004). In: Program and Abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract no. K-1535 Aisenberg G, Rolston K, Kontoyiannis DM, Raad I, Safdar A (2005) Stenotrophomonas maltophilia pneumonia (SmP) in 108 patients with cancer: matched case-control analysis in 44 individuals with low-risk of infection (1998–2004). In: Program and Abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract no. K-1535
22.
Zurück zum Zitat Cherif H, Kronvall G, Bjorkholm M, Kalin M (2003) Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. Hematol J 4:420–426PubMedCrossRef Cherif H, Kronvall G, Bjorkholm M, Kalin M (2003) Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. Hematol J 4:420–426PubMedCrossRef
23.
Zurück zum Zitat Lai CH, Chi CY, Chen HP, Chen TL, Lai CJ, Fung CP, Yu KW, Wong WW, Liu CY (2004) Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect 37:350–358PubMed Lai CH, Chi CY, Chen HP, Chen TL, Lai CJ, Fung CP, Yu KW, Wong WW, Liu CY (2004) Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect 37:350–358PubMed
24.
Zurück zum Zitat Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR (2002) Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis 34:1653–1656PubMedCrossRef Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR (2002) Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis 34:1653–1656PubMedCrossRef
25.
Zurück zum Zitat Raad I, Alrahwan A, Rolston K (1998) Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis 26:1182–1187PubMedCrossRef Raad I, Alrahwan A, Rolston K (1998) Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis 26:1182–1187PubMedCrossRef
26.
Zurück zum Zitat Micozzi A, Venditti M, Monaco M, Taglietti F, Santilli S, Martino P (2000) Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 31:705–711PubMedCrossRef Micozzi A, Venditti M, Monaco M, Taglietti F, Santilli S, Martino P (2000) Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 31:705–711PubMedCrossRef
27.
Zurück zum Zitat Martino R, Gomez L, Pericas R, Salazar R, Sola C, Sierra J, Garau J (2000) Bacteremia caused by non-glucose-fermenting gram-negative bacilli and Aeromonas species in patients with haematological malignancies and solid tumors. Eur J Clin Microbiol Infect Dis 19:320–323PubMedCrossRef Martino R, Gomez L, Pericas R, Salazar R, Sola C, Sierra J, Garau J (2000) Bacteremia caused by non-glucose-fermenting gram-negative bacilli and Aeromonas species in patients with haematological malignancies and solid tumors. Eur J Clin Microbiol Infect Dis 19:320–323PubMedCrossRef
Metadaten
Titel
Changing trends in etiology of bacteremia in patients with cancer
verfasst von
A. Safdar
G. H. Rodriguez
M. Balakrishnan
J. J. Tarrand
K. V. I. Rolston
Publikationsdatum
01.08.2006
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 8/2006
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-006-0173-4

Weitere Artikel der Ausgabe 8/2006

European Journal of Clinical Microbiology & Infectious Diseases 8/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO2. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Zeitschrift für Allgemeinmedizin, DEGAM

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.